Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Prelevic

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of the Royal Society of Medicine|December 6, 2001
Osteoporosis in menG M Prelevic
Current Opinion in Obstetrics & Gynecology|June 1, 1997
Insulin resistance in polycystic ovary syndromeG M Prelevic
Climacteric : the Journal of the International Menopause Society|March 26, 2002
Is there a proven place for phytoestrogens in the menopause?J Ginsburg, G M Prelevic
Lancet (London, England)|February 16, 2000
Lack of significant hormonal effects and controlled trials of phyto-oestrogensJ Ginsburg, G M Prelevic
Maturitas|November 1, 1994
The effect of oestrogen and progestogen replacement therapy on systolic flow velocity in healthy postmenopausal womenG M Prelevic, T Beljic
Menopause (New York, N.Y.)|March 21, 2001
Antiatherosclerotic effects of tiboloneJ Ginsburg, G M Prelevic
Menopause (New York, N.Y.)|June 22, 1999
Tibolone and the serum lipid/lipoprotein profile: does this have a role in cardiovascular protection in postmenopausal women?J Ginsburg, G M Prelevic
Maturitas|May 1, 1996
Cause of vaginal bleeding in postmenopausal women taking tiboloneJ Ginsburg, G M Prelevic
Bailliere'S Clinical Endocrinology and Metabolism|July 1, 1997
Menopause and post-menopauseG M Prelevic, H S Jacobs
Current Opinion in Obstetrics & Gynecology|June 1, 1997
New developments in postmenopausal hormone replacement therapyG M Prelevic, H S Jacobs
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of the Royal Society of Medicine|December 6, 2001
Osteoporosis in menG M Prelevic
Current Opinion in Obstetrics & Gynecology|June 1, 1997
Insulin resistance in polycystic ovary syndromeG M Prelevic
Climacteric : the Journal of the International Menopause Society|March 26, 2002
Is there a proven place for phytoestrogens in the menopause?J Ginsburg, G M Prelevic
Lancet (London, England)|February 16, 2000
Lack of significant hormonal effects and controlled trials of phyto-oestrogensJ Ginsburg, G M Prelevic
Maturitas|November 1, 1994
The effect of oestrogen and progestogen replacement therapy on systolic flow velocity in healthy postmenopausal womenG M Prelevic, T Beljic
Menopause (New York, N.Y.)|March 21, 2001
Antiatherosclerotic effects of tiboloneJ Ginsburg, G M Prelevic
Menopause (New York, N.Y.)|June 22, 1999
Tibolone and the serum lipid/lipoprotein profile: does this have a role in cardiovascular protection in postmenopausal women?J Ginsburg, G M Prelevic
Maturitas|May 1, 1996
Cause of vaginal bleeding in postmenopausal women taking tiboloneJ Ginsburg, G M Prelevic
Bailliere'S Clinical Endocrinology and Metabolism|July 1, 1997
Menopause and post-menopauseG M Prelevic, H S Jacobs
Current Opinion in Obstetrics & Gynecology|June 1, 1997
New developments in postmenopausal hormone replacement therapyG M Prelevic, H S Jacobs
Pageof 4